US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist

2.395
+0.015+0.63%

Close May 10 16:00 ET

2.390
-0.005-0.20%

Post 16:04 ET

97.31MMarket Cap9.21P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-50.43%1.34M

0.00%674K

0.00%666K

199.00%2.7M

-0.29%681K

0.15%682K

1.35%674K

666K

Operating revenue

-50.43%1.34M

--0

0.00%674K

0.00%666K

199.00%2.7M

-0.29%681K

0.15%682K

1.35%674K

--666K

Cost of revenue

Gross profit

Operating expense

-60.49%17.11M

-62.80%3.88M

-67.39%2.89M

-63.07%4.47M

-50.71%5.87M

227.29%43.3M

28.77%10.42M

30.48%8.87M

118.53%12.09M

11.92M

Selling and administrative expenses

-48.04%8.14M

-32.86%2.11M

-45.06%1.94M

-9.20%2.64M

-76.21%1.45M

273.53%15.66M

39.80%3.14M

171.70%3.52M

75.00%2.91M

--6.08M

-Selling and marketing expense

-115.51%-287K

--0

-243.20%-663K

-49.47%192K

-68.81%184K

106.12%1.85M

--418K

--463K

--380K

--590K

-General and administrative expense

-39.00%8.43M

-22.56%2.11M

-15.09%2.6M

-3.16%2.45M

-77.00%1.26M

319.15%13.81M

21.21%2.73M

136.01%3.06M

52.16%2.53M

--5.49M

Research and development costs

-67.54%8.97M

-75.73%1.77M

-82.10%957K

-80.16%1.82M

-24.14%4.43M

205.84%27.64M

24.52%7.28M

-2.82%5.35M

137.24%9.18M

--5.84M

Operating profit

61.16%-15.77M

60.20%-3.88M

64.67%-2.89M

66.80%-3.79M

53.71%-5.21M

-229.37%-40.6M

-31.44%-9.74M

-33.85%-8.19M

-134.53%-11.42M

-11.25M

Net non-operating interest income expense

28.76%4.59M

-44.61%905K

-137.74%-391K

608.00%2.48M

193.57%1.6M

2,214.29%3.56M

344.25%1.63M

110.14%1.04M

34.62%350K

544K

Non-operating interest income

124.63%8.03M

114.00%3.52M

-58.01%435K

608.00%2.48M

193.57%1.6M

2,175.80%3.57M

--1.64M

--1.04M

--350K

--544K

Non-operating interest expense

--2.04M

--1.21M

--826K

----

--0

----

Total other finance cost

15,455.56%1.4M

----

800.00%9K

----

Other net income (expense)

2,682.22%16.27M

-659.04%-630K

Gain on sale of security

2,682.22%16.27M

----

-659.04%-630K

----

Income before tax

113.51%5.09M

252.20%13.3M

54.09%-3.28M

88.14%-1.31M

66.28%-3.61M

-207.34%-37.66M

-21.57%-8.74M

-27.16%-7.15M

-140.17%-11.07M

-10.71M

Income tax

100K

Net income

113.47%5.09M

252.20%13.3M

54.72%-3.28M

88.14%-1.31M

66.28%-3.61M

-208.15%-37.76M

-21.57%-8.74M

-28.94%-7.25M

-140.17%-11.07M

-10.71M

Net income continuous Operations

113.47%5.09M

252.20%13.3M

54.72%-3.28M

88.14%-1.31M

66.28%-3.61M

-208.15%-37.76M

-21.57%-8.74M

-28.94%-7.25M

-140.17%-11.07M

---10.71M

Minority interest income

63.67%-437K

79.27%-40K

67.88%-62K

77.72%-119K

23.67%-216K

-104.94%-1.2M

42.04%-193K

53.83%-193K

-534K

-283K

Net income attributable to the parent company

115.11%5.53M

256.10%13.34M

54.36%-3.22M

88.66%-1.19M

67.43%-3.4M

-213.34%-36.56M

-24.66%-8.54M

-35.59%-7.06M

-128.58%-10.53M

-10.43M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

115.11%5.53M

256.10%13.34M

54.36%-3.22M

88.66%-1.19M

67.43%-3.4M

-213.34%-36.56M

-24.66%-8.54M

-35.59%-7.06M

-128.58%-10.53M

-10.43M

Basic earnings per share

114.89%0.14

250.00%0.33

55.56%-0.08

88.89%-0.03

70.37%-0.08

-203.23%-0.94

-4.76%-0.22

-5.88%-0.18

-58.82%-0.27

-0.27

Diluted earnings per share

114.89%0.14

250.00%0.33

55.56%-0.08

88.89%-0.03

70.37%-0.08

-203.23%-0.94

-4.76%-0.22

-5.88%-0.18

-58.82%-0.27

-0.27

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	-50.43%1.34M	0	0	0.00%674K	0.00%666K	199.00%2.7M	-0.29%681K	0.15%682K	1.35%674K	666K
Operating revenue	-50.43%1.34M	--0	--0	0.00%674K	0.00%666K	199.00%2.7M	-0.29%681K	0.15%682K	1.35%674K	--666K
Cost of revenue
Gross profit
Operating expense	-60.49%17.11M	-62.80%3.88M	-67.39%2.89M	-63.07%4.47M	-50.71%5.87M	227.29%43.3M	28.77%10.42M	30.48%8.87M	118.53%12.09M	11.92M
Selling and administrative expenses	-48.04%8.14M	-32.86%2.11M	-45.06%1.94M	-9.20%2.64M	-76.21%1.45M	273.53%15.66M	39.80%3.14M	171.70%3.52M	75.00%2.91M	--6.08M
-Selling and marketing expense	-115.51%-287K	--0	-243.20%-663K	-49.47%192K	-68.81%184K	106.12%1.85M	--418K	--463K	--380K	--590K
-General and administrative expense	-39.00%8.43M	-22.56%2.11M	-15.09%2.6M	-3.16%2.45M	-77.00%1.26M	319.15%13.81M	21.21%2.73M	136.01%3.06M	52.16%2.53M	--5.49M
Research and development costs	-67.54%8.97M	-75.73%1.77M	-82.10%957K	-80.16%1.82M	-24.14%4.43M	205.84%27.64M	24.52%7.28M	-2.82%5.35M	137.24%9.18M	--5.84M
Operating profit	61.16%-15.77M	60.20%-3.88M	64.67%-2.89M	66.80%-3.79M	53.71%-5.21M	-229.37%-40.6M	-31.44%-9.74M	-33.85%-8.19M	-134.53%-11.42M	-11.25M
Net non-operating interest income expense	28.76%4.59M	-44.61%905K	-137.74%-391K	608.00%2.48M	193.57%1.6M	2,214.29%3.56M	344.25%1.63M	110.14%1.04M	34.62%350K	544K
Non-operating interest income	124.63%8.03M	114.00%3.52M	-58.01%435K	608.00%2.48M	193.57%1.6M	2,175.80%3.57M	--1.64M	--1.04M	--350K	--544K
Non-operating interest expense	--2.04M	--1.21M	--826K	----	----	--0	--0	--0	----	----
Total other finance cost	15,455.56%1.4M	----	----	----	----	800.00%9K	----	----	----	----
Other net income (expense)	2,682.22%16.27M					-659.04%-630K
Gain on sale of security	2,682.22%16.27M	----	----	----	----	-659.04%-630K	----	----	----	----
Income before tax	113.51%5.09M	252.20%13.3M	54.09%-3.28M	88.14%-1.31M	66.28%-3.61M	-207.34%-37.66M	-21.57%-8.74M	-27.16%-7.15M	-140.17%-11.07M	-10.71M
Income tax	0	0	0			100K	0	100K
Net income	113.47%5.09M	252.20%13.3M	54.72%-3.28M	88.14%-1.31M	66.28%-3.61M	-208.15%-37.76M	-21.57%-8.74M	-28.94%-7.25M	-140.17%-11.07M	-10.71M
Net income continuous Operations	113.47%5.09M	252.20%13.3M	54.72%-3.28M	88.14%-1.31M	66.28%-3.61M	-208.15%-37.76M	-21.57%-8.74M	-28.94%-7.25M	-140.17%-11.07M	---10.71M
Minority interest income	63.67%-437K	79.27%-40K	67.88%-62K	77.72%-119K	23.67%-216K	-104.94%-1.2M	42.04%-193K	53.83%-193K	-534K	-283K
Net income attributable to the parent company	115.11%5.53M	256.10%13.34M	54.36%-3.22M	88.66%-1.19M	67.43%-3.4M	-213.34%-36.56M	-24.66%-8.54M	-35.59%-7.06M	-128.58%-10.53M	-10.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	115.11%5.53M	256.10%13.34M	54.36%-3.22M	88.66%-1.19M	67.43%-3.4M	-213.34%-36.56M	-24.66%-8.54M	-35.59%-7.06M	-128.58%-10.53M	-10.43M
Basic earnings per share	114.89%0.14	250.00%0.33	55.56%-0.08	88.89%-0.03	70.37%-0.08	-203.23%-0.94	-4.76%-0.22	-5.88%-0.18	-58.82%-0.27	-0.27
Diluted earnings per share	114.89%0.14	250.00%0.33	55.56%-0.08	88.89%-0.03	70.37%-0.08	-203.23%-0.94	-4.76%-0.22	-5.88%-0.18	-58.82%-0.27	-0.27
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall